Jul 11, 2020-Saturday

select city

Metro cities - Delhi, Mumbai, Chennai, Kolkata

Other cities - Noida, Gurgaon, Bengaluru, Hyderabad, Bhopal , Chandigarh , Dehradun, Indore, Jaipur, Lucknow, Patna, Ranchi

Saturday, Jul 11, 2020
ADVERTISEMENT

Gilead

Jul 10, 2020 19:15
Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as in the study. read more
Jul 09, 2020 00:07
Doctors blame increased demand and limited supply of the medicine for its shortage since the Union health ministry on June 13 allowed its emergency use for treating Covid-19 patients with moderate symptoms. read more
Jun 29, 2020 19:53
The price tag is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review (ICER), last week. read more
Jun 26, 2020 04:18
The European healthcare regulator has recommended the conditional approval of Gilead Sciences Inc’s antiviral treatment, remdesivir, for use in Covid-19 patients, making it the first treatment to be on track to be green-lit in the continent. read more
Jun 21, 2020 09:11
With this development, India is soon to begin the domestic production of anti-viral drug remdesivir which would have efficacy, stability, safety for “restricted emergency use” on Covid-19 patients, official added. read more
Jun 18, 2020 12:44
From experimental drug remdesivir making strides to generic steroid drug dexamethasone emerging as the first Covid-19 drug, the race to developing the antidote to Covid-19 is getting more interesting by the day. read more
Jun 13, 2020 15:39
Dr Reddy’s Laboratories Ltd, Biocon arm Syngene International Ltd, Zydus Cadila Ltd, and Egypt-based Eva Pharma Pvt Ltd are the companies Gilead has entered into non-exclusive voluntary licensing agreements with. read more
Jun 12, 2020 20:33
Remdesivir, the investigational drug from Gilead Sciences Inc, has been issued an ‘emergency use authorisation’ (EUA) by the United States Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of coronavirus, Zydus Cadila said in a statement. read more
Jun 09, 2020 15:41
In the study, macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study authors. read more
Jun 08, 2020 04:43
AstraZeneca, valued at $140 billion, is the U.K.’s biggest drugmaker by market capitalization and has developed treatments for conditions from cancer to cardiovascular disease. read more
May 30, 2020 12:13
California-based Gilead has said it will donate 1.5 million doses of remdesivir, enough to treat at least 140,000 patients, to combat the global pandemic. read more
May 29, 2020 08:33
Roche said in a statement that it had joined forces with Gilead for a global phase III clinical trial evaluating the safety and efficacy of using tocilizumab combined with remdesivir in hospitalised patients with severe Covid-19 pneumonia. read more
May 12, 2020 21:23
Remdesivir, an investigational anti-viral therapy developed by Gilead, received Emergency Use Authorisation (EUA) by USFDA to treat Covid-19. read more
May 07, 2020 06:49
Coronavirus update: The discussion is taking place about their ability, under voluntary licenses, to produce remdesivir for Europe, Asia and the developing world through at least 2022. read more
May 03, 2020 03:27
The emergency authorisation allows products to be used for treatment without full data on their safety and efficacy, which has to be still submitted as trials continue. read more